4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000127
EVP, Chief Technical Ops. Off. sold 2,650 shares at $475.34 ($1,259,651)
- EVP, Chief Technical Ops. Off. gave up 2,482 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Atkinson Edward Morrow III · EVP, Chief Technical Ops. Off.
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-26 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −2,482 | $479.61 | $1,190,392 | 22,002 | D |
| 2025-02-27 | Sale : show line 2 in the form 10b5-1 | −2,650 | $475.34 | $1,259,651 | 19,352 | D |
| Open-market sales · 2,650 sh · avg $475.34 · $1,259,651 | ||||||
Loading xslF345X05/wk-form4_1740778570.xml…